澳大利亚缺铁性贫血治疗市场 – 行业趋势和 2028 年预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Medical Devices Australia Iron Deficiency Anemia Therapy Market
请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

澳大利亚缺铁性贫血治疗市场 – 行业趋势和 2028 年预测

  • Medical Devices
  • Published Report
  • Aug 2021
  • Country Level
  • 350 页面
  • 桌子數： 7
  • 图号： 26
立即购买 立即购买

>澳大利亚缺铁性贫血治疗市场，按治疗（口服铁剂治疗、肠外铁剂治疗）、治疗领域（妇产科、肾病、充血性心力衰竭 (CHF)、炎症性肠病、肿瘤科、其他）、人口（成人、儿科）、国家（澳大利亚）划分。行业趋势和预测至 2028 年。    

市场分析和见解：澳大利亚缺铁性贫血治疗市场

预计澳大利亚缺铁性贫血治疗市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2021 年至 2028 年的预测期内，该市场将以 8.9% 的复合年增长率增长，预计到 2028 年将达到 5941 万美元。妊娠期血液稀释病例的增加和缺铁患病率的上升提高了对铁和叶酸补充剂的需求，从而成为缺铁性贫血治疗市场增长的驱动力。

贫血是指人体没有足够的红细胞将氧气输送到组织的一种疾病。血红蛋白是红细胞中的蛋白质，负责将氧气输送到组织。缺铁性贫血是最常见的贫血类型，指的是人体缺乏矿物质铁。人体需要铁来制造血红蛋白。

贫血有多种诱发因素。从临床角度来看，贫血常见于患有慢性炎症、感染或恶性肿瘤（如癌症、类风湿性关节炎、肾病和心力衰竭）的患者。此外，在没有患慢性疾病的人群中，贫血主要是由微量营养素缺乏、传染病和遗传易感性引起的。缺铁性贫血 (IDA) 是全世界最常见的营养性贫血原因。育龄妇女缺铁性贫血的最常见原因是月经量过多或怀孕导致血液中铁流失。缺铁性贫血的症状起初可能很轻微，例如全身疲劳、皮肤苍白、虚弱、头晕和头痛等。缺铁可通过口服铁疗法、肠外铁疗法和其他补充剂等治疗。

贫血患病率的上升、妊娠期血液稀释病例的增加以及缺铁性贫血的诊断和评估的增加预计将推动市场增长。另一方面，铁补充剂的副作用可能会阻碍澳大利亚缺铁性贫血治疗市场的增长。

医疗支出的上涨或许为澳大利亚缺铁性贫血治疗市场带来机遇。然而，严格的法规和监管是该市场面临的挑战之一。

这份澳大利亚缺铁性贫血治疗市场报告提供了市场份额、新发展和产品线分析的详细信息，国内和本地市场参与者的影响，分析了新兴收入来源、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报。我们的团队将帮助您创建收入影响解决方案，以实现您的预​​期目标。

澳大利亚缺铁性贫血治疗市场贫血缺铁性贫血治疗市场范围及市场规模

澳大利亚缺铁性贫血治疗市场根据治疗、治疗区域和人口进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。

  • 根据治疗方法，澳大利亚缺铁性贫血治疗市场分为口服铁剂治疗和肠外铁剂治疗。由于澳大利亚贫血患病率高，预计 2021 年口服铁剂治疗将占据市场主导地位。
  • 根据治疗领域，澳大利亚缺铁性贫血治疗市场细分为妇产科、肾病、充血性心力衰竭、炎症性肠病、肿瘤科等。2021 年，妇产科领域将因月经和妊娠出血而占据市场主导地位。
  • 根据人口，澳大利亚缺铁性贫血治疗市场分为成人和儿童。2021 年，成人市场预计将占据市场主导地位，因为成人慢性病患病率较高，从而导致贫血。

澳大利亚缺铁性贫血治疗市场国家级分析

对澳大利亚缺铁性贫血治疗市场进行了分析，并按上述治疗方法、治疗区域和人口提供了市场规模信息。

由于孕妇对贫血状况和适当铁补充剂消费的认识不断提高，预计澳大利亚铁产品市场将在 2021 年至 2028 年的预测期内以最高增长率增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测各个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了澳大利亚品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战，销售渠道的影响。

主要市场参与者不断增加的战略活动，以提高人们对妊娠贫血的认识，正在推动澳大利亚缺铁性贫血治疗市场的增长

澳大利亚缺铁性贫血治疗市场还为您提供了每个国家在特定市场增长的详细市场分析。此外，它还提供有关市场参与者的战略及其地理分布的详细信息。数据适用于 2010 年至 2019 年的历史时期。

竞争格局和澳大利亚缺铁性贫血治疗市场份额分析

澳大利亚缺铁性贫血治疗市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对澳大利亚缺铁性贫血治疗市场的关注有关。

从事澳大利亚缺铁性贫血治疗的主要公司包括 Aspen Pharmacare Australia Pty Ltd.、Pharmacare Laboratories Australia、AFT Pharmaceuticals、BLACKMORES、Pfizer Inc.、Merck KGaA、Australian NaturalCare、Thorne、Vifor Pharma Management Ltd.、SHIELD THERAPEUTICS、Sanofi、Fresenius Kabi AG、PHARMACOSMOS A/C、GlaxoSmithKline plc 以及其他国内公司。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。

全球各地的公司也签订了许多合同和协议，这也加速了澳大利亚缺铁性贫血治疗市场的发展。

例如，

  • 2021年4月，赛诺菲宣布成功完成对临床阶段生物制药公司Kiadis的收购。此次收购增强了公司的治疗策略，从而提高了公司在该市场的整体收入
  • 2021 年 11 月，辉瑞公司宣布其 Upjohn 部门与 Mylan NV 合并，成立了一家名为 Viatris 的新公司。该公司业务部门与 Mylan NV 的合并增加了其产品组合，从而增加了市场对其产品的需求。市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业和其他战略正在增强该公司在澳大利亚缺铁性贫血治疗市场的影响力，这也为该组织的利润增长带来了好处

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of Australia iron deficiency anemia therapy market
    4. Currency and pricing
    5. LIMITATIONS
    6. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. DBMR TRIPOD DATA VALIDATION MODEL
    5. primary interviews with key opinion leaders
    6. MULTIVARIATE MODELLING
    7. Therapy LIFELINE CURVE
    8. DBMR MARKET POSITION GRID
    9. MARKET APPlication COVERAGE GRID
    10. vendor share analysis
    11. secondary sourcEs
    12. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insight
  5. regulatory Framework
  6. epidemiology
  7. Summary Write Up
    1. OVERVIEW
  8. Pipeline analysis
  9. Market Overview
    1. Drivers
      1. RISING PREVALENCE OF Anemia
      2. Increasing cases of hemodialtion in pregnancy
      3. INCREASING PREVALENCE OF CHRONIC DISEASES
      4. Rising Diagnosis and evaluation of Iron-deficieny anemia (IDA)
    2. Restraint
      1. side effects associated with IDA drugs
    3. OPPORTUNITIES
      1. STRATEGIC INITIATIVES TAKEN BY MARKET PLAYERS
      2. RISING EXPENDITURE ON HEALTHCARE
    4. Challenge
      1. Stringent regulation policy
  10. COVID-19 IMPACT ON Australia Iron Deficiency Anaemia Therapy Market
    1. impact on price
    2. impact on demand
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISIONS of Government and MANUFACTURERS
    5. Conclusion
  11. AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET, By therapy
    1. OVERVIEW
    2. ORAL IRON THERAPY
      1. IRON II GLYCINATE (BISGLYCINATE)
      2. FERRIC MALTOL
      3. IRON SUCROSE
      4. FERROUS FUMARATE
      5. IRON POLYMALTOSE
      6. OTHERS
    3. Parenteral iron therapy
      1. FERRIC DERISOMALTOSE
      2. FERRIC CARBOXYMALTOSE
      3. IRON SUCROSE
      4. IRON DEXTRAN
      5. FERROUS FUMARATE
      6. IRON DEXTRAN
      7. FERROUS FUMARATE
      8. FERRIC CITRATE
      9. IRON ISOMALTOSIDE
      10. OTHERS
  12. AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET, By therapy area
    1. OVERVIEW
    2. OBSTETRICS AND GYNECOLOGY
    3. RENAL
      1. DIALYSIS
      2. NON-DIALYSIS
    4. CONGESTIVE HEART FAILURE (CHF)
    5. INFLAMMATORY BOWEL DISEASE
    6. ONCOLOGY
    7. OTHERS
  13. Australia iron deficiency anemia therapy market, By population
    1. overview
    2. adults
    3. pediatric
  14. Australia iron deficiency anemia therapy market: COMPANY landscape
    1. company share analysis: Australia
  15. swot analysis
  16. company profile
    1. SANOFI
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. Product Portfolio
      4. RECENT DEVELOPMENTs
    2. pfizer Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    3. MERCK KGAA
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    4. VIFOR PHARMA MANAGEMENT LTD.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    5. GLAXOSMITHKLINE PLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    6. AFT PHARMACEUTICALS
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. ASPEN PHARMACARE AUSTRALIA PTY LTD
      1. OMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    8. AUSTRALIAN NATURALCARE
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    9. BLACKMORES
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    10. FRESENIUS KABI Ag
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. Product Portfolio
      4. Recent Development
    11. PHARMACARE LABORATORIES AUSTRALIA.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. PHARMACOSMOS A/S
      1. COMPANY SNAPSHOT
      2. Product Portfolio
      3. Recent Development
    13. SHIELD THERAPEUTICS
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    14. THORNE
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  17. questionnaire
  18. related reports

表格列表

TABLE 1 IRON-DEFICIENCY ANEMIA THERAPY Market, pipeline analysis

TABLE 2 AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET, By therapy, 2019-2028 (USD million)

TABLE 3 Australia Oral Iron therapy in Iron deficiency Anemia therapy Market, By therapy, 2019-2028 (USD Million)

TABLE 4 Australia Parenteral Iron therapy in Iron deficiency Anemia therapy Market, By therapy, 2019-2028 (USD Million)

TABLE 5 Australia Iron deficiency Anemia therapy Market, By therapy Area, 2019-2028 (USD Million)

TABLE 6 Australia Renal in Iron deficiency Anemia therapy Market, By therapy Area, 2019-2028 (USD Million)

TABLE 7 Australia Iron deficiency Anemia therapy Market, By Population, 2019-2028 (USD Million)

图片列表

FIGURE 1 Australia iron deficiency anemia therapy market: segmentation

FIGURE 2 Australia iron deficiency anemia therapy market: data triangulation

FIGURE 3 Australia iron deficiency anemia therapy market: DROC ANALYSIS

FIGURE 4 Australia iron deficiency anemia therapy market: country VS regional MARKET ANALYSIS

FIGURE 5 Australia iron deficiency anemia therapy market: COMPANY RESEARCH ANALYSIS

FIGURE 6 Australia iron deficiency anemia therapy market: INTERVIEW DEMOGRAPHICS

FIGURE 7 Australia iron deficiency anemia therapy market: DBMR MARKET POSITION GRID

FIGURE 8 Australia iron deficiency anemia therapy market: MARKET application COVERAGE GRID

FIGURE 9 Australia iron deficiency anemia therapy market: vendor share analysis

FIGURE 10 Australia iron deficiency anemia therapy market: SEGMENTATION

FIGURE 11 high prevalence of anemia is expected to drive the Australia iron deficiency anemia therapy market in the forecast period of 2021 to 2028

FIGURE 12 oral iron therapy segment is expected to account for the largest share of the Australia iron deficiency anemia therapy market in 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINT, OPPORTUNITIES, AND CHALLENGE OF australia IRON DEFICIENCY ANEMIA THERAPY market

FIGURE 14 AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET: By therapy, 2020

FIGURE 15 AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET: By therapy, 2019-2028 (USD million)

FIGURE 16 AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET: By therapy, CAGR (2021-2028)

FIGURE 17 AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET: By therapy, LIFELINE CURVE

FIGURE 18 AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET: By therapy AREA, 2020

FIGURE 19 AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET: By therapy AREA, 2021-2028 (USD million)

FIGURE 20 AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET: By therapy AREA, CAGR (2021-2028)

FIGURE 21 AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET: By therapy AREA, LIFELINE CURVE

FIGURE 22 Australia iron deficiency anemia therapy markeT: By POPULATION, 2020

FIGURE 23 Australia iron deficiency anemia therapy markeT: By POPULATION, 2019-2028 (USD million)

FIGURE 24 Australia iron deficiency anemia therapy markeT: By POPULATION, CAGR (2021-2028)

FIGURE 25 Australia iron deficiency anemia therapy markeT: By POPULATION, LIFELINE CURVE

FIGURE 26 Australia iron deficiency anemia therapy market: company share 2020 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

浏览相关页面

Banner